PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26536665-0	2016	Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.	INK128	20-27	mechanistic target of rapamycin kinase	Homo sapiens	5-9	
26536665-4	2016	Recently, MLN0128, a second-generation dual TORC1/2 inhibitor is shown to have therapeutic efficacy in preclinical studies.	INK128	10-17	CREB regulated transcription coactivator 1	Homo sapiens	44-51	
26536665-10	2016	Finally, we also observe robust antitumor effects of MLN0128 when administered as a dual therapy with JQ1, a bromodomain protein BRD4 inhibitor.	INK128	53-60	bromodomain containing 4	Homo sapiens	129-133